D. Back

发表

Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population

M. Youle, C. Smith, T. Mahungu, 2009, HIV medicine.

The impact of pharmacogenetics on HIV therapy

T. Mahungu, Andrew Owen, Margaret Johnson, 2009, International journal of STD & AIDS.

Improved Oral Bioavailability of Lopinavir in Melt-Extruded Tablet Formulation Reduces Impact of Third Trimester on Lopinavir Plasma Concentrations

S. Khoo, D. Back, L. Dickinson, 2011, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteers.

B. Gazzard, S. Khoo, S. Emery, 2011, The Journal of antimicrobial chemotherapy.

Effect of etretinate on cyclosporin metabolism in vitro

D. Back, I. Webbbr, D. Back, 1993, The British journal of dermatology.

Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure‐activity relationship

D. Back, J. Tjia, J.F. Tjia, 1985, British journal of pharmacology.

The intracellular pharmacology of antiretroviral protease inhibitors.

S. Khoo, J. Ford, D. Back, 2004, The Journal of antimicrobial chemotherapy.

Cortisol metabolism in vitro—III. Inhibition of microsomal 6β—hydroxylase and cytosolic 4-ene-reductase

S. M. Abel, D. Back, 1993, The Journal of Steroid Biochemistry and Molecular Biology.

The Relationships of ABCB1 3435C>T and CYP2B6 516G>T With High‐Density Lipoprotein Cholesterol in HIV‐Infected Patients Receiving Efavirenz

M. Youle, S. Khoo, C. Smith, 2009, Clinical pharmacology and therapeutics.

Dexamethasone metabolism in vitro: Species differences

B. K. Park, E. Tomlinson, D. Back, 1997, The Journal of Steroid Biochemistry and Molecular Biology.

The pharmacogenomics of HIV therapy

M. Pirmohamed, D. Back, D. Back, 2001, The Pharmacogenomics Journal.

Principles and practice of HIV‐protease inhibitor pharmacoenhancement

D. Back, G. Moyle, G. Moyle, 2001, HIV medicine.

Pharmacogenetics of pregnancy‐induced changes in efavirenz pharmacokinetics

L. Else, O. Bolaji, A. Olagunju, 2015, Clinical pharmacology and therapeutics.